New analysis examines RAP-219’s effect during the first month of treatment and consistency of efficacy over the treatment ...

UNC researchers discovered how a key step in cell signaling works by showing exactly how G proteins detach from receptors ...

A dissident stockholder, Lynx1 Master Fund LP (“Lynx1”), has nominated two candidates for election to the Board of Directors of the Company (the “Board”). Neuphoria urges its stockholders to vote “ ...

Vanderbilt University has divulged muscarinic M1 receptor positive allosteric modulators (PAMs) reported to be useful for the treatment of pain, Alzheimer’s disease, schizophrenia, attention deficit ...

At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story of ...

Marking its 10th anniversary, Frontiers Health returns to Berlin at the bcc Berlin Congress Center for a milestone edition bringing together industry leaders, startups, investors, health care systems, ...